TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 50 filers reported holding TELA BIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $504,945 | -76.3% | 107,435 | -71.4% | 0.00% | – |
| Q1 2024 | $2,128,337 | +0.3% | 375,368 | +17.1% | 0.00% | – |
| Q4 2023 | $2,121,995 | -4.9% | 320,543 | +14.9% | 0.00% | – |
| Q3 2023 | $2,230,976 | -21.8% | 278,872 | -1.0% | 0.00% | – |
| Q2 2023 | $2,853,368 | +780.3% | 281,675 | +824.6% | 0.00% | – |
| Q1 2023 | $324,148 | -53.7% | 30,465 | -50.0% | 0.00% | – |
| Q4 2022 | $700,696 | +215.6% | 60,930 | +133.8% | 0.00% | – |
| Q3 2022 | $222,000 | +20.0% | 26,065 | 0.0% | 0.00% | – |
| Q2 2022 | $185,000 | -38.9% | 26,065 | 0.0% | 0.00% | – |
| Q1 2022 | $303,000 | -1.0% | 26,065 | +9.1% | 0.00% | – |
| Q4 2021 | $306,000 | -6.1% | 23,898 | 0.0% | 0.00% | – |
| Q3 2021 | $326,000 | +7.6% | 23,898 | +27.1% | 0.00% | – |
| Q2 2021 | $303,000 | -80.4% | 18,798 | -81.9% | 0.00% | – |
| Q1 2021 | $1,547,000 | +8.0% | 103,796 | +9.0% | 0.00% | – |
| Q4 2020 | $1,433,000 | +32.1% | 95,262 | +45.2% | 0.00% | – |
| Q3 2020 | $1,085,000 | +36.1% | 65,610 | +6.7% | 0.00% | – |
| Q2 2020 | $797,000 | – | 61,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,110,709 | $19,320,332 | 6.30% |
| Stonepine Capital Management, LLC | 625,645 | $2,940,532 | 2.70% |
| AIGH Capital Management LLC | 1,656,655 | $7,786,278 | 2.42% |
| Velan Capital Investment Management LP | 746,087 | $3,506,609 | 2.01% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,700,000 | 1.11% |
| PERKINS CAPITAL MANAGEMENT INC | 204,350 | $960 | 0.90% |
| Nantahala Capital Management | 2,445,667 | $11,494,635 | 0.68% |
| Meros Investment Management, LP | 152,718 | $717,775 | 0.34% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,256,200 | $5,904,140 | 0.27% |
| Orbimed Advisors | 2,457,542 | $11,550,447 | 0.23% |